A study involving more than 7,600 colorectal cancer patients found those who took statins were 29% less likely to die from the condition and 25% less likely to die from any cause compared to nonusers. The risk of death decreased further with more than a year of statin usage. The findings appeared in the Journal of Clinical Oncology.

Full Story:
HealthDay News

Related Summaries